Mabwell (Shanghai) Bioscience Co., Ltd.

Mabwell (Shanghai) Bioscience Co., Ltd.verified

688062.SS

Price:

$43.05

Market Cap:

$17.20B

Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of biological products in China and internationally. The company offers its products for auto-immune, oncology, ophthalmologic, and infectious diseases, as well as metabolic disorders, etc. It offers JUNMAIKANG, an autoimmune Adalimumab injection. The company’s oncology products pipeline includes 9MW2821 and 6MW3211, which are in phase II of clinical trial; 9MW2921, 9MW3811, and 7MW3711, which are in phase I clinical trials; 9MW0321; and 8MW0511, which is in phase III clinical trial. It also develops autoimmune products, such as 9MW1911 and 9MW38...[Read more]

Industry

Biotechnology

IPO Date

2022-01-18

Stock Exchange

SHH

Ticker

688062.SS

The Current Ratio as of December 2025 (TTM) for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) is 0.90

According to Mabwell (Shanghai) Bioscience Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.90. This represents a change of -6.46% compared to the average of 0.96 of the last 4 quarters.

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Historical Current Ratio (quarterly & annually)

How has 688062.SS Current Ratio performed in the past?

The mean historical Current Ratio of Mabwell (Shanghai) Bioscience Co., Ltd. over the last ten years is 1.99. The current 0.90 Current Ratio has changed 4.44% with respect to the historical average. Over the past ten years (40 quarters), 688062.SS's Current Ratio was at its highest in in the March 2022 quarter at 11.45. The Current Ratio was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

1.99

Median

1.01

Minimum

0.22

Maximum

6.24

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mabwell (Shanghai) Bioscience Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 710.09%

Maximum Annual Current Ratio = 6.24

Minimum Annual Increase = -77.37%

Minimum Annual Current Ratio = 0.22

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.11-55.90%
20232.51-59.81%
20226.24589.56%
20210.91-77.37%
20204.00710.09%
20190.49122.70%
20180.22-47.43%

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Average Current Ratio

How has 688062.SS Current Ratio performed in the past?

The current Current Ratio of Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.28

5-year avg

2.95

10-year avg

1.99

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) Current Ratio vs. Peers

How is 688062.SS’s Current Ratio compared to its peers?

Mabwell (Shanghai) Bioscience Co., Ltd.’s Current Ratio is less than Anhui Anke Biotechnology (Group) Co., Ltd. (3.78), less than Inner Mongolia Furui Medical Science Co., Ltd. (5.00), less than DaShenLin Pharmaceutical Group Co., Ltd. (0.96), less than Yunnan Botanee Bio-Technology Group Co.LTD (3.64), less than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (2.46), less than Beijing Hotgen Biotech Co., Ltd. (5.07), less than Tibet Cheezheng Tibetan Medicine Co., Ltd. (2.63), less than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (0.98), less than Beijing Aosaikang Pharmaceutical Co., Ltd. (2.72), less than Andon Health Co., Ltd. (4.77),

Build a custom stock screener for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mabwell (Shanghai) Bioscience Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mabwell (Shanghai) Bioscience Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Mabwell (Shanghai) Bioscience Co., Ltd.'s Current Ratio?

How is the Current Ratio calculated for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the highest Current Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the 3-year average Current Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

What is the 5-year average Current Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS)?

How does the current Current Ratio for Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) compare to its historical average?